1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > PharmaPoint: Colorectal Cancer - Current and Future Players

PharmaPoint: Colorectal Cancer - Current and Future Players

  • November 2014
  • -
  • Global Data
  • -
  • 59 pages

PharmaPoint: Colorectal Cancer - Current and Future Players

Summary

GlobalData has released its pharma report, “PharmaPoint: Colorectal Cancer - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Colorectal Cancer Market. The report identifies and analyses the key companies shaping and driving the global Colorectal Cancer market. The report provides insight into the competitive Colorectal Cancer landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Colorectal Cancer
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Colorectal Cancer sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Colorectal Cancer market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Colorectal Cancer market landscape? Identify, understand and capitalize

Table Of Contents

PharmaPoint: Colorectal Cancer - Current and Future Players
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
2.3 Upcoming Related Reports 13
3 Market Outlook 14
3.1 Global Markets 14
3.1.1 Forecast 14
3.1.2 Drivers and Barriers - Global Issues 18
4 Current and Future Players 21
4.1 Overview 21
4.2 Trends in Corporate Strategy 25
4.3 Company Profiles 26
4.3.1 Roche/Genentech 26
4.3.2 Sanofi 29
4.3.3 Eli Lilly and Company 32
4.3.4 Merck KGaA 35
4.3.5 Bayer 38
4.3.6 Taiho Pharmaceutical 41
5 Appendix 45
5.1 Bibliography 45
5.2 Abbreviations 49
5.3 Methodology 51
5.4 Forecasting Methodology 51
5.4.1 Diagnosed Colorectal Cancer Patients 51
5.4.2 Percent Drug-Treated Patients 52
5.4.3 General Pricing Assumptions 52
5.4.4 Average Body Weight and Surface Area Across the 8MM 53
5.4.5 Generic Erosion 53
5.5 Primary Research - KOLs Interviewed for this Report 54
5.6 Primary Research - Prescriber Survey 55
5.7 About the Authors 56
5.7.1 Analyst 56
5.7.2 Global Head of Healthcare 57
5.8 About GlobalData 58
5.9 Disclaimer 58

1.1 List of Tables
Table 1: Sales Forecasts ($m) for Colorectal Cancer in the Global Markets, 2013-2023 16
Table 2: CRC Market Drivers and Barriers, 2014 18
Table 3: Key Companies in the CRC Market in the 8MM, 2013-2023 23
Table 4: Roche's CRC Portfolio Assessment, 2014 28
Table 5: Sanofi's CRC Portfolio Assessment, 2014 31
Table 6: Eli Lilly's CRC Portfolio Assessment, 2014 34
Table 7: Merck KGaA's CRC Portfolio Assessment, 2014 37
Table 8: Bayer's CRC Portfolio Assessment, 2014 40
Table 9: Taiho's CRC Portfolio Assessment, 2014 43
Table 10: Average Body Weight and Surface Area Across the 8MM 53
Table 11: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 55

1.2 List of Figures
Figure 1: Global Sales for Colorectal Cancer by Region, 2013-2023 17
Figure 2: Global Sales of Branded Products for Colorectal Cancer by Company, 2013-2023 24
Figure 3: Company Portfolio Gap Analysis in CRC, 2013-2023 25
Figure 4: Roche SWOT Analysis in CRC, 2014 29
Figure 5: Sanofi SWOT Analysis in CRC, 2014 32
Figure 6: Eli Lilly SWOT Analysis in CRC, 2014 35
Figure 7: Merck KGaA SWOT Analysis in CRC, 2014 38
Figure 8: Bayer SWOT Analysis in CRC, 2014 41
Figure 9: Taiho SWOT Analysis in CRC, 2014 44

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Colorectal Cancer Diagnostics & Therapeutics Market

Global Colorectal Cancer Diagnostics & Therapeutics Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global colorectal cancer diagnostics and therapeutics market is expected to grow at a CAGR of around 6% during the forecast period 2016-2021. The market is estimated to be valued at USD 8000 million ...

US Market Report for Virtual Colonoscopy 2017 - MedCore

US Market Report for Virtual Colonoscopy 2017 - MedCore

  • $ 3995
  • Industry report
  • October 2016
  • by iData Research, Inc.

Some of the major factors driving units down are an unfavorable reimbursement structure and strong lobbying against using colonography as one of the key colon cancer screening methods. Most of sales have ...

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025

  • $ 3995
  • Industry report
  • December 2016
  • by Global Data

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025 Summary Colorectal cancer (CRC) is a cancer that starts in the colon or the rectum (ACS, 2016). CRC is one of the most common types of ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.